JCR Pharmaceuticals Competitors and Similar CompaniesClear all
JCR Pharmaceuticals's competitors and similar companies include Travere Therapeutics, Kiora Pharmaceuticals, Occurx and Certa Therapeutics.
 JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  Kiora Pharmaceuticals Kiora Pharmaceuticals (formerly known as Panoptes Pharma) is a clinical-stage biotech company focused on developing small molecule-based therapies for the treatment of severe eye diseases. |  Occurx OccuRx is a company developing therapies for the treatment of ocular inflammation and fibrosis. |  Certa Therapeutics Certa Therapeutics is a biotechnology company developing therapies for the treatment of fibrotic diseases. | |
Founding Date | Founding Date 1975 | Founding Date 2011 | Founding Date 2013 | Founding Date 2014 | Founding Date N/A |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations San Diego, US HQ Dublin, IE | Locations Wien, AT HQ | Locations Melbourne, AU HQ | Locations HQ |
Employees | Employees 934 | Employees 46293% increase | Employees 1025% increase | Employees 16 | Employees 12 |
Valuation ($) | Valuation ($) 533.9 m | Valuation ($) 1.4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥33.1b (FY, 2025) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥8b (FY, 2025) | Cost of goods $10.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥25.1b (FY, 2025) | Gross profit $480.4m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income (¥4.7b) (FY, 2025) | Net income ($25.5m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Travere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyKiora Pharmaceuticals
HQ
Wien, AT
Kiora Pharmaceuticals (formerly known as Panoptes Pharma) is a clinical-stage biotech company focused on developing small molecule-based therapies for the treatment of severe eye diseases.
View companyOccurx
HQ
Melbourne, AU
OccuRx is a company developing therapies for the treatment of ocular inflammation and fibrosis.
View companyCerta Therapeutics
HQ
Employees
12
Certa Therapeutics is a biotechnology company developing therapies for the treatment of fibrotic diseases.
View company